These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 37408276)

  • 41. Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.
    Martin LJ; Chang Q
    Mol Neurobiol; 2012 Feb; 45(1):30-42. PubMed ID: 22072396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.
    Paez-Colasante X; Figueroa-Romero C; Sakowski SA; Goutman SA; Feldman EL
    Nat Rev Neurol; 2015 May; 11(5):266-79. PubMed ID: 25896087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
    Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
    Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site.
    Flomen R; Makoff A
    Neurosci Lett; 2011 Jun; 497(2):139-43. PubMed ID: 21569822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Potential Connection between Molecular Changes and Biomarkers Related to ALS and the Development and Regeneration of CNS.
    Glavač D; Mladinić M; Ban J; Mazzone GL; Sámano C; Tomljanović I; Jezernik G; Ravnik-Glavač M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [ALS and excitatory amino acid].
    Aizawa H; Kwak S
    Brain Nerve; 2007 Oct; 59(10):1117-27. PubMed ID: 17969352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis.
    Ravnik-Glavač M; Glavač D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis.
    Liu J; Zhou F; Guan Y; Meng F; Zhao Z; Su Q; Bao W; Wang X; Zhao J; Huo Z; Zhang L; Zhou S; Chen Y; Wang X
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronological and Biological Aging in Amyotrophic Lateral Sclerosis and the Potential of Senolytic Therapies.
    Dashtmian AR; Darvishi FB; Arnold WD
    Cells; 2024 May; 13(11):. PubMed ID: 38891059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic and transcriptomic advances in amyotrophic lateral sclerosis.
    Rizzuti M; Sali L; Melzi V; Scarcella S; Costamagna G; Ottoboni L; Quetti L; Brambilla L; Papadimitriou D; Verde F; Ratti A; Ticozzi N; Comi GP; Corti S; Gagliardi D
    Ageing Res Rev; 2023 Dec; 92():102126. PubMed ID: 37972860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
    Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
    J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis.
    Di Pietro L; Lattanzi W; Bernardini C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
    Roberts B; Theunissen F; Mastaglia FL; Akkari PA; Flynn LL
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis.
    Nishimoto Y; Nakagawa S; Hirose T; Okano HJ; Takao M; Shibata S; Suyama S; Kuwako K; Imai T; Murayama S; Suzuki N; Okano H
    Mol Brain; 2013 Jul; 6():31. PubMed ID: 23835137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Old versus New Mechanisms in the Pathogenesis of ALS.
    Rossi S; Cozzolino M; Carrì MT
    Brain Pathol; 2016 Mar; 26(2):276-86. PubMed ID: 26779612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons.
    Capauto D; Colantoni A; Lu L; Santini T; Peruzzi G; Biscarini S; Morlando M; Shneider NA; Caffarelli E; Laneve P; Bozzoni I
    Mol Neurobiol; 2018 Oct; 55(10):7635-7651. PubMed ID: 29430619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.